Clinical Trials Logo
  1. Home
  2. Other
  3. NCT03334110

A Clinical Randomized Controlled Trial of the New Method of Selective Coronary Vein Bypass Graft (SCVBG)

Coronary Atherosclerotic Heart Disease Clinical Trial

Official title:
Clinical Randomized Controlled Trial of the New Method of Selective Coronary Venous Bypass Graft on Improving Curative Effects in Patients With Diffuse Coronary Artery Disease

Clinical Trial Summary

Apply a new operation method of Left Internal Mammary Artery (LIMA)-Greater Saphenous Vein (GSV)-SCVBG to the treatment of patients with diffuse coronary artery disease,through clinical randomized controlled study,compared with patients of bilateral internal mammary artery (BIMA)-SCVBG and evaluate both of therapeutic effects and prognosis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03334110
Study type Interventional
Source Beijing Anzhen Hospital
Contact
Status Recruiting
Phase N/A
Start date November 30, 2017
Completion date September 2018
View Details
See also
  Status Clinical Trial Phase
Completed NCT02807532 - Relationship Between Apelin and New-onset Atrial Fibrillation After Coronary Artery Bypass Grafting N/A